Regulatory PathRegulatory requirements compared

Active substance

Nandrolone

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
DECADURABOLIN ORGAJECT 25MG-ML25 mg/mlSolution · Intravenous use1 AmpouleSAR 18.85Generic · PrescriptionORGANONWithdrawn by MAH · Not Marketed
DECADURABOLIN ORGAJECT 50MG-ML50 mg/mlSolution · Intravenous use1 AmpouleSAR 36.25Generic · PrescriptionORGANONWithdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
DECA-DURABOLIN50MG/ML; 100MG/ML; 200MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**injectable · injectionWOODWARD SPECLDiscontinued5 Oct 1962
NANDROLONE DECANOATE200MG/MLinjectable · injectionABRAXIS PHARMDiscontinued14 Oct 1983
NANDROLONE DECANOATE200MG/MLinjectable · injectionWATSON LABSDiscontinued5 Dec 1983
NANDROLONE DECANOATE50MG/MLinjectable · injectionWATSON LABSDiscontinued13 Jan 1984
NANDROLONE DECANOATE100MG/MLinjectable · injectionWATSON LABSDiscontinued13 Jan 1984
NANDROLONE DECANOATE200MG/MLinjectable · injectionAM REGENTDiscontinued30 Aug 2010
NANDROLONE DECANOATE100MG/MLinjectable · injectionEPIC PHARMA LLCDiscontinued
NANDROLONE DECANOATE50MG/MLinjectable · injectionWATSON LABSDiscontinued
NANDROLONE DECANOATE100MG/MLinjectable · injectionWATSON LABSDiscontinued
NANDROLONE DECANOATE100MG/MLinjectable · injectionABRAXIS PHARMDiscontinued
NANDROLONE DECANOATE50MG/MLinjectable · injectionWATSON LABSDiscontinued
NANDROLONE DECANOATE50MG/MLinjectable · injectionQUAD PHARMSDiscontinued
NANDROLONE DECANOATE100MG/MLinjectable · injectionQUAD PHARMSDiscontinued
NANDROLONE DECANOATE200MG/MLinjectable · injectionQUAD PHARMSDiscontinued

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.